Latest news with #TongkatAli

Associated Press
04-08-2025
- Business
- Associated Press
Nootropics Depot's Tongkat Ali Declared Most Cost-Efficient and Potent in Industry, According to Independent Lab Tests
TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading choice for both cost efficiency and potency, dramatically outpacing seven major competitors. This robust data, generated by advanced Ultra-Performance Liquid Chromatography (UPLC), positions Nootropics Depot as the category benchmark for quality and transparency in the Tongkat Ali supplement market. Key findings highlight: These results are detailed in a transparent, third-party report and set a new standard for evidence-based supplement selection. 'We've always believed the best way to earn customer trust is transparency,' said Paul Eftang, CEO of Nootropics Depot. 'This independent lab data is validation for consumers. Not only are we delivering more of Tongkat Ali's active compounds, we're setting the bar for value, potency, and scientific rigor in an industry notorious for marketing hype.' 'Consumers deserve clear, standardized information so they can make meaningful health decisions — not just clever branding and proprietary blends,' Eftang added. 'We invite every brand to publish their own lab results. This is how the industry should operate.' Nootropics Depot offers three main Tongkat Ali options: Additionally, the company's transparent and published testing methods allow consumers to easily compare products, moving the supplement industry toward higher standards of honesty and efficacy. Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media Contact Michael Packman Marketing Manager Nootropics Depot [email protected] View original content to download multimedia: SOURCE Nootropics Depot
Yahoo
04-08-2025
- Business
- Yahoo
Nootropics Depot's Tongkat Ali Declared Most Cost-Efficient and Potent in Industry, According to Independent Lab Tests
TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading choice for both cost efficiency and potency, dramatically outpacing seven major competitors. This robust data, generated by advanced Ultra-Performance Liquid Chromatography (UPLC), positions Nootropics Depot as the category benchmark for quality and transparency in the Tongkat Ali supplement market. Key findings highlight: Nootropics Depot's 10% eurycomanone extract delivers 18.0mg of active eurycomanone per dollar, a 3.3x cost advantage over the nearest competitor and up to 40x more value than premium-priced brands. Its 10% extract provides 10–12mg of lab-verified eurycomanone per 100mg dose, while competitors typically yield only 0.13–4mg per dose. Cost per mg of eurycomanone for Nootropics Depot's 10% extract is just $0.06, compared to $0.20 to $5.77 from competitors, leading to as much as 96x more active compounds per dollar spent. These results are detailed in a transparent, third-party report and set a new standard for evidence-based supplement selection. "We've always believed the best way to earn customer trust is transparency," said Paul Eftang, CEO of Nootropics Depot. "This independent lab data is validation for consumers. Not only are we delivering more of Tongkat Ali's active compounds, we're setting the bar for value, potency, and scientific rigor in an industry notorious for marketing hype." "Consumers deserve clear, standardized information so they can make meaningful health decisions — not just clever branding and proprietary blends," Eftang added. "We invite every brand to publish their own lab results. This is how the industry should operate." Nootropics Depot offers three main Tongkat Ali options: Tongkat Ali 10% Tablets: Highest potency, delivering up to 12mg eurycomanone per 100mg dose. Tongkat Ali 2% Capsules: Full-spectrum, balanced option with 4mg per 200mg dose. Eurycomax Optimized Stack: Combines two extraction methods with synergistic ingredients for broader hormonal support. Additionally, the company's transparent and published testing methods allow consumers to easily compare products, moving the supplement industry toward higher standards of honesty and efficacy. Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media ContactMichael PackmanMarketing ManagerNootropics Depotmichael@ View original content to download multimedia: SOURCE Nootropics Depot Sign in to access your portfolio

Associated Press
16-07-2025
- Health
- Associated Press
Nootropics Depot Unveils Eurycomax, an Optimized Tongkat Ali Stack
TEMPE, Ariz., July 16, 2025 /PRNewswire/ -- Nootropics Depot, a leading manufacturer of research-backed dietary supplements, announced the launch of Eurycomax, its most advanced Tongkat Ali formulation to date. The dual-extract stack pairs a 10% eurycomanone Tongkat Ali with a cold-water ultrasonic extract and five synergistic ingredients—Horny Goat Weed, Mucuna pruriens, pregnenolone, boron, and iodine—to support healthy testosterone, motivation, and recovery in a single daily serving. Designed for Balanced Testosterone Support Eurycomax delivers 7 mg of eurycomanone per two-capsule serving while preserving a broad spectrum of quassinoids through the novel cold-water extract. 'Our R&D goal was to capture the full breadth of Tongkat Ali's bioactives without sacrificing potency,' said Paul Eftang, CEO of Nootropics Depot. 'Combining targeted standardization with ultrasonic extraction lets us do that in a clinically meaningful dose.' Key bioactives include: Backed by ISO-Accredited Testing All raw materials and finished batches undergo identity, potency, and contaminant screening in Nootropics Depot's ISO/IEC 17025-accredited analytical laboratory. Certificates of analysis are posted on each product page, continuing the company's 'Transparency You Can See' ethos. Addressing Real-World Feedback Formulation decisions were informed by five years of customer blood-work data and anecdotal reports on classic Tongkat Ali side effects such as low estradiol, joint discomfort, and rising prolactin. Eurycomax counterbalances these issues by integrating icariin and L-DOPA at tolerable levels. 'People love Tongkat Ali's drive and strength gains but don't want hormone imbalances in month three,' Eftang noted. 'Eurycomax smooths the curve so users feel motivated, resilient, and consistent in the gym and at work.' Availability Eurycomax is now shipping worldwide through in 60-capsule bottles (30-day supply). 'Quality is everything to us. With Eurycomax we didn't just raise health and vitality—we raised the standard for nutraceutical stacks that respect the whole endocrine picture,' said Eftang. For more on the science and story behind Eurycomax, listen to the full podcast interview with Nootropics Depot's product specialist Emiel Bakker: About Nootropics Depot Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media Contact Michael Packman Marketing Manager Nootropics Depot [email protected] View original content to download multimedia: SOURCE Nootropics Depot


Korea Herald
06-06-2025
- Health
- Korea Herald
Biotropics Malaysia Berhad Signs Strategic MOU with ASK Intercity Co., Ltd. to Bring Physta® Tongkat Ali to the Japanese Market
KUALA LUMPUR, June 6, 2025 /PRNewswire/ -- In a significant move to advance natural, evidence-based health solutions in Japan, Biotropics Malaysia Berhad has signed a Memorandum of Understanding (MOU) with ASK Intercity Co., Ltd. for the sales and distribution of Physta ® Tongkat Ali, Biotropics' proprietary standardized extract, in the Japanese market. The MOU signing took place at the Malaysian Pavillion of the World Expo Osaka 2025, during the opening of 'Sustainable Agriculture Week' witnessed by The Honorable Datuk Seri Haji Mohamad bin Sabu, Minister of Agriculture and Food Security. This partnership unites two companies with a shared commitment to the development and marketing of high-quality, clinically supported herbal ingredients. With decades of industry experience, both companies are dedicated to raising the standards of natural product innovation through scientific rigor, transparency and product integrity. Physta ® Tongkat Ali, developed through a landmark collaboration between the Malaysian Government and the Massachusetts Institute of Technology (MIT), stands as one of the world's most clinically studied Tongkat Ali (Eurycoma longifolia) extracts. It is backed by over 20 clinical studies and has been shown to support energy, vitality, libido, immunity, stress management and hormonal health. Recently, new research from Biotropics has uncovered Physta ® 's efficacy in supporting hormonal balance and reducing stress in pre- and postmenopausal women—a breakthrough expansion from its earlier positioning as a male-centric supplement. This positions Physta ® as a versatile ingredient for a broader demographic, supporting both men and women in managing age-related health challenges naturally. "In light of Japan's rapidly ageing population and growing demand for preventive, plant-based health solutions, we believe Physta ® brings timely and relevant benefits," said Haliza Ramli, CEO of Biotropics Malaysia. "There is a surge of interest for Tongkat Ali globally and this collaboration reflects a mutual vision: to deliver clinically supported, high-quality herbal ingredients that meet the needs of discerning, health-conscious consumers." Koichi Hosaka, CEO and Managing Director of ASK Intercity, added, "We are excited to work with Biotropics, a globally respected leader in herbal research. Tongkat Ali is already recognized internationally, and we believe Physta ® will be very appealing to Japanese consumers seeking natural vitality, stress support, hormonal balance and even looking for Power of Malaysian original forest". The partnership arrives at a pivotal time: Japan has the world's oldest population, with over 29% aged 65 and above. As healthy ageing becomes a national priority, ingredients like Physta ® —with proven benefits and gender-inclusive applications—offer real value to brand owners formulating for this dynamic segment. The MOU aims to redefine natural wellness in one of Asia's most mature and discerning health markets and sets foundation for future cooperation between Malaysia and Japan in the field of herbal science, innovation and market development. Biotropics' portfolio—including BioKesum ®, SLP+ ®, Nu-Femme ®, and Eurecta ® —continues to expand, driven by strong IP, clinical validation and Malaysia's rich botanical heritage.
Yahoo
06-06-2025
- Health
- Yahoo
Biotropics Malaysia Berhad Signs Strategic MOU with ASK Intercity Co., Ltd. to Bring Physta® Tongkat Ali to the Japanese Market
KUALA LUMPUR, June 6, 2025 /PRNewswire/ -- In a significant move to advance natural, evidence-based health solutions in Japan, Biotropics Malaysia Berhad has signed a Memorandum of Understanding (MOU) with ASK Intercity Co., Ltd. for the sales and distribution of Physta® Tongkat Ali, Biotropics' proprietary standardized extract, in the Japanese market. The MOU signing took place at the Malaysian Pavillion of the World Expo Osaka 2025, during the opening of 'Sustainable Agriculture Week' witnessed by The Honorable Datuk Seri Haji Mohamad bin Sabu, Minister of Agriculture and Food Security. This partnership unites two companies with a shared commitment to the development and marketing of high-quality, clinically supported herbal ingredients. With decades of industry experience, both companies are dedicated to raising the standards of natural product innovation through scientific rigor, transparency and product integrity. Physta® Tongkat Ali, developed through a landmark collaboration between the Malaysian Government and the Massachusetts Institute of Technology (MIT), stands as one of the world's most clinically studied Tongkat Ali (Eurycoma longifolia) extracts. It is backed by over 20 clinical studies and has been shown to support energy, vitality, libido, immunity, stress management and hormonal health. Recently, new research from Biotropics has uncovered Physta®'s efficacy in supporting hormonal balance and reducing stress in pre- and postmenopausal women—a breakthrough expansion from its earlier positioning as a male-centric supplement. This positions Physta® as a versatile ingredient for a broader demographic, supporting both men and women in managing age-related health challenges naturally. "In light of Japan's rapidly ageing population and growing demand for preventive, plant-based health solutions, we believe Physta® brings timely and relevant benefits," said Haliza Ramli, CEO of Biotropics Malaysia. "There is a surge of interest for Tongkat Ali globally and this collaboration reflects a mutual vision: to deliver clinically supported, high-quality herbal ingredients that meet the needs of discerning, health-conscious consumers." Koichi Hosaka, CEO and Managing Director of ASK Intercity, added, "We are excited to work with Biotropics, a globally respected leader in herbal research. Tongkat Ali is already recognized internationally, and we believe Physta® will be very appealing to Japanese consumers seeking natural vitality, stress support, hormonal balance and even looking for Power of Malaysian original forest". The partnership arrives at a pivotal time: Japan has the world's oldest population, with over 29% aged 65 and above. As healthy ageing becomes a national priority, ingredients like Physta®—with proven benefits and gender-inclusive applications—offer real value to brand owners formulating for this dynamic segment. The MOU aims to redefine natural wellness in one of Asia's most mature and discerning health markets and sets foundation for future cooperation between Malaysia and Japan in the field of herbal science, innovation and market development. Biotropics' portfolio—including BioKesum®, SLP+®, Nu-Femme®, and Eurecta®—continues to expand, driven by strong IP, clinical validation and Malaysia's rich botanical heritage. View original content to download multimedia: SOURCE Biotropics Malaysia